Evaluation of the vascular protective effects of new oral anticoagulants in high-risk patients with atrial fibrillation (PREFER-AF): study protocol for a randomized controlled trial

BACKGROUND: Atrial fibrillation (AF) is known to be associated with several pathophysiological mechanisms including endothelial dysfunction of the heart and arterial vessels. Recent evidence suggests that new oral anticoagulant (NOAC) treatment may improve endothelial function and the inflammatory p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jin-Bae, Joung, Hyun Jun, Lee, Jung Myung, Woo, Jong Shin, Kim, Woo-shik, Kim, Kwon Sam, Lee, Kyung Hye, Kim, Weon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997652/
https://www.ncbi.nlm.nih.gov/pubmed/27558002
http://dx.doi.org/10.1186/s13063-016-1541-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997652/
https://www.ncbi.nlm.nih.gov/pubmed/27558002
http://dx.doi.org/10.1186/s13063-016-1541-8

Ejemplares similares